Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation (Forbes)

Forbes: Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation  —  Surbhi Sarna sold her last startup, nVision Medical, for $275 million.  Now she's leaving a partner role at Y Combinator to launch Collate …

Jan 19, 2025 - 10:00
18219
Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation (Forbes)

Forbes:
Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation  —  Surbhi Sarna sold her last startup, nVision Medical, for $275 million.  Now she's leaving a partner role at Y Combinator to launch Collate …

This article has been sourced from various publicly available news platforms around the world. All intellectual property rights remain with the original publishers and authors. Unshared News does not claim ownership of the content and provides it solely for informational and educational purposes voluntarily. If you are the rightful owner and believe this content has been used improperly, please contact us for prompt removal or correction.